The Regulatory Expectations for Environmental Monitoring Programs
- Speaker:Kenneth Christie
- Product Code:GRC-90472
Live Session - How it works
- Username and Password will be sent to you within 24 hours prior to the webinar.
Recorded Session - How it works
- Please click on the link to access the Recording and type in the password provided in the email.
- Presentation and other handouts will be emailed to you in a pdf format.
Training CD - How it works
(For more information about our products contact +1- 248-233-2049)
If you are unable to attend the meeting Live then you can opt in for the Live Recording instead. Access the Recording of the Training for 6 months. Contact our support for any questions. To prepare an invoice to pay by Check or Wire email us at email@example.com.
Understand the importance of an effective environmental monitoring (EM) program and its place in your organization. This course will provide insights on regulatory requirements governing EM programs, contamination control practices, and common deficiencies cited by regulatory auditors when auditing EM programs.
The establishment of EM programs is critical to the success of aseptic, terminal sterilization and non-sterile manufacturing facilities as it is a tool for evaluating the adequacy of cleaning programs, personnel gowning and contamination control practices.
This course will focus on three major points:
- The regulatory requirements for environmental monitoring
- The main issues with EM programs such as monitoring locations and the justifications for them, the types of sampling, and the establishment of operational limits
- The handling of excursions and some of the common deficiencies cited by regulatory auditors
The webinar will also discuss issues dealing with contamination control practices such as minimizing bio-burden levels, batch residuals, proper gowning requirements and personnel training. To promote better understanding of the subject, an actual case study of an EM excursion will be used to help attendees apprehend the depth of investigations expected; the decision process used to evaluate its impact on product produced; and learn the agency’s opinion on the investigation performed and their ruling.
The webinar will demonstrate how EM programs provide meaningful information on the quality of the aseptic processing environment (e.g., when a given batch is being manufactured) as well as environmental trends of ancillary clean areas.
At the end of the session, attendees will be encouraged to ask questions and discuss issues relating to their own EM program.
- Review the current regulatory requirements and guidances (CFR, EU GMPs, ISO, etc.) for environmental monitoring.
- Discuss issues of sampling methods, selection of sampling sites and the justifications for them.
- Review the issue of contamination control as an important aspect of EM programs.
- Discuss the issue of action and alert limits, trending of data and the handling of excursions.
- What are the most common deficiencies cited by regulatory auditors when auditing environmental monitoring programs?
- Attendee question and answer period.
Who can Attend:
- Quality Assurance
- Quality Control
- Regulatory affairs
- Laboratory Personnel
- Equipment Vendors
Kenneth Christie has over 30 years of sterile manufacturing and regulatory GMP consulting experience in the areas of quality assurance and validation management in the pharmaceutical and biotechnology industries. Mr. Christie is currently the chief operating officer for VTS Consultants, Inc., located in Amhesrt, MA. His responsibilities specifically include quality system auditing, GMP training, and serving as a subject matter expert for aseptic manufacturing processes, medical devices, APIs and solid dosage processing equipment, utilities, and systems on a global basis. He also performs vendor audits, site pre-approval inspections and assists clients with addressing and correcting regulatory observations.
Mr. Christie was the validation manager at Parke-Davis' Sterile Products Facility where he was involved in the review and approval of all facilities, equipment, and system commissioning/qualification activities. He had routine interaction with the FDA and European inspectors (EMEA), corporate management and third party contract-manufacturing representatives to defend validation practices and to assure regulatory compliance for the manufacture of aseptically produced products.
Mr. Christie is a speaker and trainer for several professional organizations in the US, Canada, Europe, and Asia and is a published author of several articles dealing with the challenges of aseptic processing. Additionally, he serves as a member of the ISPE’s Professional Certification (PCC) Commission as an Examination Development Committee (EDC) member.
Mr. Christie has a BS degree in biology from Shippensburg State University (PA) and an executive MBA degree from Michigan State.